Preprint · CC-BY
via OpenAlex
Uncertainty-Aware Ranking of Geroprotective Interventions from Public Lifespan Data: A Sentinel Cross-Species Benchmark
Zenodo (CERN European Organization for Nuclear Research) · 2026
Abstract
This is a secondary analysis of a sentinel public-record extract. It is not an exhaustive DrugAge meta-analysis, a clinical study, or a treatment recommendation. Public longevity databases contain heterogeneous observations collected across species, strains, sexes, doses, treatment windows and experimental laboratories. Ranking interventions directly from the largest reported lifespan extension therefore rewards extreme and weakly replicated records. We present a reproducible sentinel benchmark for evidence-aware prioritization of geroprotective interventions. The benchmark contains 58 explicitly enumerated records from an open DrugAge snapshot, representing 15 compounds, 24 independent compound–publication–species units and seven model organisms. Records were first aggregated within publication and species to reduce pseudo-replication from dose and sex strata. Candidate-level evidence was then represented by a capped effect component, a Wilson lower bound on the fraction of significant-positive study units, and study/species breadth. We combined these features in a transparent ranking and separately applied a non-compensatory gate requiring replication across at least two studies and two species, with positive study-level effects throughout. Aspirin, metformin, fisetin and curcumin occupied the top four positions in all 5,000 plausible score-weight draws, but the underlying evidence included unusually reported doses, small numbers of independent studies and large cross-context effects. Five compounds passed the strict gate, including 2,4-dinitrophenol, illustrating that lifespan evidence alone cannot substitute for safety, pharmacokinetic or mechanistic assessment. mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">Rapamycin(definition) ranked below several cross-species candidates because the sentinel extract contained replicated mouse evidence but no second species, despite consistent positive mouse effects. The central result is therefore methodological: effect magnitude, reproducibility, cross-species breadth and safety must remain separate decision dimensions. This benchmark is not an exhaustive DrugAge meta-analysis and isnot a clinical recommendation. It provides a compact, auditable test bed for future transcriptomic, toxicological and virtual-tissue intervention models.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5281/zenodo.21455803
- Canonical
- link ↗
- Fetched
- 2026-10-13 MST
Cite this
APA
Paunova, E. (2026). Uncertainty-Aware Ranking of Geroprotective Interventions from Public Lifespan Data: A Sentinel Cross-Species Benchmark. <em>Zenodo (CERN European Organization for Nuclear Research)</em>. https://doi.org/10.5281/zenodo.21455803
Vancouver
Paunova E. Uncertainty-Aware Ranking of Geroprotective Interventions from Public Lifespan Data: A Sentinel Cross-Species Benchmark. Zenodo (CERN European Organization for Nuclear Research). 2026. doi:10.5281/zenodo.21455803.
BibTeX
@unpublished{eva2026Uncert,
title = {Uncertainty-Aware Ranking of Geroprotective Interventions from Public Lifespan Data: A Sentinel Cross-Species Benchmark},
author = {Eva Paunova},
journal = {Zenodo (CERN European Organization for Nuclear Research)},
year = {2026},
doi = {10.5281/zenodo.21455803},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2016
Open access · CC-BY
Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer
Scientific reports 2026
Citation only
Systematic review and meta-analysis of the effects of exercise in older adults with sarcopenia.
Aging 2014
Open access · OA
Rapamycin in preventive (very low) doses
Aging cell 2026
Open access · OA
Exploring the Role of Transposable Elements to Sex Gap in Longevity in Three Drosophila Species.
SciVision Biotech Inc. 2021
Open access · US-GOV
The Evaluation of the Safety and Effectiveness of ANIMERS Chiara LA and JUVÉDERM VOLUMA® for Aging Mid-Face
BMC Public Health 2023
Open access · CC-BY